Cambridge, UK, March 21 2012: Horizon Discovery (Horizon), a leading provider of research tools to support the development and prescription of personalized medicines, has been awarded 'Business of the Year' by a panel of judges in the Business Weekly Awards. The presentation ceremony took place on March 20 at Queens’ College, Cambridge.
According to Business Weekly, the Business of the Year was chosen from a shortlist of companies, from which the judging panel looked for a company that had not only made extraordinary progress in 2011, but had also taken sufficient strides to achieve global leadership in their field.
“We’re delighted to accept this award from Business Weekly,” commented Darrin Disley, CEO, Horizon. “The team worked hard throughout 2011, and continues to do so, to negotiate partnerships and deals that not only drive the business forward, but help to create a community of scientists working in the personalized medicine field, with a focus on the application of rAAV-mediated gene editing technology.”
Founded in 2007, Horizon has become one of the fastest growing biotech companies in Europe and now occupies a 20,000 sq. ft. of state-of-art research facility in Cambridge, UK. The company has grown its top-line revenue by greater than 100 per cent every year since foundation, growth that is built upon a customer base that includes 100 academic, biotechnology, diagnostic and pharmaceutical companies.